PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 129 filers reported holding PROTAGONIST THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 4.22 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,848,144 | +20.8% | 110,800 | +100.0% | 0.00% | 0.0% |
| Q2 2023 | $1,530,148 | +129.4% | 55,400 | +91.0% | 0.00% | +100.0% |
| Q1 2023 | $667,000 | +58.1% | 29,000 | +62.5% | 0.00% | – |
| Q1 2022 | $422,000 | -62.7% | 17,842 | -46.0% | 0.00% | -100.0% |
| Q4 2021 | $1,130,000 | +35.5% | 33,042 | -29.8% | 0.00% | 0.0% |
| Q3 2021 | $834,000 | -75.5% | 47,042 | -31.7% | 0.00% | -66.7% |
| Q2 2021 | $3,403,000 | +113.8% | 68,842 | +12.0% | 0.00% | +50.0% |
| Q1 2021 | $1,592,000 | +54.1% | 61,471 | +19.9% | 0.00% | +100.0% |
| Q4 2020 | $1,033,000 | +34.3% | 51,252 | +30.2% | 0.00% | 0.0% |
| Q3 2020 | $769,000 | +10.6% | 39,353 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $695,000 | – | 39,353 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 2,449,183 | $56,331,209 | 18.32% |
| Kynam Capital Management, LP | 1,375,000 | $31,625,000 | 4.08% |
| BVF INC/IL | 3,775,900 | $86,845,700 | 3.18% |
| Cormorant Asset Management, LP | 1,700,000 | $39,100 | 2.58% |
| RTW INVESTMENTS, LP | 4,600,799 | $105,818,377 | 2.20% |
| Ghost Tree Capital, LLC | 225,000 | $5,175,000 | 1.53% |
| 683 Capital Management, LLC | 791,000 | $18,193,000 | 1.36% |
| Ikarian Capital, LLC | 211,400 | $4,862,200 | 1.10% |
| Ikarian Capital, LLC | 211,400 | $4,862,200 | 1.10% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 105,486 | $2,426,178 | 1.00% |